Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

7.770 -0.230 (-2.88%)
Streaming Delayed Price Updated: 3:00 PM EDT, Jun 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought This Week ↗
The widely followed growth stock investor is adding to some of her holdings this week. 
Via The Motley Fool
News headline image
Evaluating Ginkgo Bioworks Holdings: Insights From 4 Financial Analysts ↗
 
Via Benzinga
News headline image
NuStar Energy, Spirit Airlines, Fastly And Other Big Stocks Moving Higher On Monday ↗
U.S. stocks traded higher, with the Dow Jones index gaining around 200 points on Monday. Shares of NuStar Energy L.P. (NYSE: NS) rose sharply during Monday’s session after Sunoco announced it will... 
Via Benzinga
Topics Stocks
News headline image
Cathie Wood's Ark Invest Sells $8.04M Worth of DraftKings Shares ↗
 
Via Benzinga
News headline image
3 Pricey Stocks I'll Be Watching Like a Hawk in 2024 ↗
Good things come to those who wait. 
Via The Motley Fool
News headline image
2 Cathie Wood Stocks That Might Be Smart Buys Right Now ↗
These two biotech stocks hold enormous potential. 
Via The Motley Fool
News headline image
Where Will Ginkgo Bioworks Be in 5 Years? ↗
Ginkgo Bioworks has been securing deals with many top companies, but will they pay off for the business? 
Via The Motley Fool
News headline image
Flexsteel Industries Posts Strong Preliminary Results, Joins Wipro, Sify Technologies And Other Big Stocks Moving Higher In Friday's Pre-Market Session ↗
U.S. stock futures were mixed this morning, with the Dow futures gaining around 50 points on Friday. 
Via Benzinga
Topics Stocks
News headline image
Analyst Assesses Cell-Programming Focused Ginkgo Bioworks' Positioning Amid Revenue Surge, Program Adjustments ↗
Wednesday, Ginkgo Bioworks Holdings Inc (NYSE: DNA) released preliminary FY23 sales of $250 million-$260 million, compared to the consensus of $258.65 million. 
Via Benzinga
News headline image
3 Cathie Wood Stocks to Start Off Your New Year Right ↗
The following stocks could deliver big gains over time. 
Via The Motley Fool
News headline image
Better Growth Investment: Ginkgo Bioworks vs. Shiba Inu ↗
Both of these investments need to prove that they can actually grow. 
Via The Motley Fool
News headline image
4 Cathie Wood Stocks Wall Street Thinks Will Skyrocket 83% to 168% in 2024 ↗
Even if Wall Street is wrong about these stocks in the new year, Cathie Wood could still be right about them over the long run. 
Via The Motley Fool
News headline image
2 Growth Stocks That Could Rocket 149% to 210% Higher in 2024, According to Wall Street ↗
Find out why investment bank analysts are hyperbullish for these stocks. 
Via The Motley Fool
News headline image
5 Innovative Stocks That Could Score a Win for Your Portfolio in 2024 ↗
You'll find exciting innovators across industries. 
Via The Motley Fool
News headline image
This Artificial Intelligence Stock Could Be Like Buying Amazon in 1997 ↗
Ginkgo Bioworks has frequently been compared to Amazon in the media. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Could Ginkgo Bioworks Stock Help You Become a Millionaire? ↗
It's easy to see a way for this to be a huge business in the future, but the path ahead of it is by no means a smooth one. 
Via The Motley Fool
News headline image
Tech Stocks Set New All-Time High, Small Caps On Fire As Wall Street Bulls Run Wild: What's Driving Markets Tuesday? ↗
Tuesday, December 19, 2023, stands now as a remarkable day in Wall Street’s history, as the technology stocks of the Nasdaq 100 mark a significant milestone, surging to new highs after a hiatus of 758... 
Via Benzinga
News headline image
As 2023 Comes To A Close And Updates Are Expected From Many Companies, Are These Three Unique Biotech Names On Your Watchlist? ↗
Biotech stocks have had a tough run in 2023 so far. As of early November, the iShares Biotechnology ETF (IBB) was down 7.5% while the S&P 500 was up more than 14%. 
Via Benzinga
Topics ETFs
News headline image
AI Meets Biotech: 3 Top Stocks Transforming Medical Science ↗
The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
5 Beaten-Down Stocks That Could Soar in 2024 ↗
These players may offer your portfolio a lift as early as next year. But most importantly, they could excel over time. 
Via The Motley Fool
News headline image
3 Dirt-Cheap Stocks to Buy Hand Over Fist Before the End of the Year ↗
These players could lift your portfolio when they rebound and over the long term. 
Via The Motley Fool
News headline image
If You Invested $1,000 in Ginkgo Bioworks in 2021, This Is How Much You Would Have Today ↗
Ginkgo's future may be promising, but whether the company can realize its potential is debatable. 
Via The Motley Fool
News headline image
Looking for Growth? 2 Top Stocks to Buy Hand Over Fist ↗
These stocks offer enormous long-term growth potential. 
Via The Motley Fool
News headline image
7 Small-Cap Stocks to Buy BEFORE the Year-End Rally ↗
explore and wager on these top small-cap stocks to buy, poised for significant gains in today's dynamic global economy 
Via InvestorPlace
News headline image
3 Synthetic Biology Stocks Likely to Mint New Millionaires ↗
Synthetic biology stocks are strongly worth considering for several reasons, particularly these three stocks. 
Via InvestorPlace
News headline image
Dutch ingredients Firm Vivici Partners With Ginkgo Bioworks For Alternative Protein Development ↗
Dutch B2B ingredients company Vivici BV has partnered with biotech company Ginkgo Bioworks Holdings Inc (NYSE: DNA) to develop and commercialize  
Via Benzinga
News headline image
2024’s Hidden Gems: 7 Small-Caps Set for Explosive Growth ↗
Small-cap stocks outperform larger companies on an indexed basis, but finding the best among them individually isn't always easy. 
Via InvestorPlace
News headline image
3 Key Trends to Consider in Ginkgo Bioworks' Q3 Earnings Report ↗
Favorable trends are continuing, but there are new headwinds too. 
Via The Motley Fool
News headline image
7 Stocks Most Likely to Follow in WeWork’s Woeful Footsteps ↗
These troubled stocks to sell look even worse following WeWork's bankruptcy and will only hurt holders the longer they hold on. 
Via InvestorPlace
Topics Bankruptcy
News headline image
3 Cutting-Edge Biotech Stocks for the Bold Investor ↗
With broader market concerns rising, investors may want to consider the relatively insulated allure of biotech stocks to buy. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.